{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:46:31Z","timestamp":1791081991242,"version":"4.1.0"},"reference-count":182,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.bbcan.2004.03.001","type":"journal-article","created":{"date-parts":[[2004,4,17]],"date-time":"2004-04-17T13:17:48Z","timestamp":1082207868000},"page":"123-143","source":"Crossref","is-referenced-by-count":46,"title":["The selective estrogen enzyme modulators in breast cancer: a review"],"prefix":"10.1016","volume":"1654","author":[{"given":"Jorge R","family":"Pasqualini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2004.03.001_BIB1","series-title":"Advances in Research and Treatment","first-page":"1","article-title":"Hormones and mammary carcinogenesis","volume":"vol. 2","author":"Segaloff","year":"1978"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB2","series-title":"Advances in Research and Treatment, Current Topics","first-page":"199","article-title":"The role of hormones in the development of human breast cancer","volume":"vol. 3","author":"Kirschner","year":"1979"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01806790","article-title":"Autocrine and paracrine growth regulation of human breast cancer","volume":"7","author":"Lippman","year":"1986","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB4","first-page":"246","article-title":"Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award Lecture","volume":"48","author":"Henderson","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/80.10.756","article-title":"Defective estrogen receptors in human mammary cancers: their significance in defining hormone dependence","volume":"80","author":"Raam","year":"1988","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB6","first-page":"105","article-title":"Variant human breast tumor estrogen receptor with constitutive transcriptional activity","volume":"51","author":"Fuqua","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0960-0760(92)90214-4","article-title":"Abnormal estrogen receptor in clinical breast cancer","volume":"43","author":"McGuire","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB8","first-page":"483","article-title":"Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors","volume":"52","author":"Fuqua","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB9","first-page":"5934","article-title":"Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line","volume":"53","author":"Castles","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB10","first-page":"457","article-title":"Estrogen and progesterone receptors in breast cancer","volume":"560","author":"Edwards","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0305-7372(88)90002-3","article-title":"Antiestrogens in the management of hormone-dependent cancer","volume":"15","author":"Litherland","year":"1988","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB12","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB13","first-page":"2548","article-title":"Evidence for involvement of BRCA1 in sporadic breast carcinomas","volume":"54","author":"Cropp","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB14","series-title":"Breast Cancer, Prognosis, Treatment, and Prevention","first-page":"555","article-title":"BRCA1, BRCA2, and hereditary breast cancer","author":"Bove","year":"2002"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB15","first-page":"2900","article-title":"Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue","volume":"45","author":"van Landeghem","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0277-5379(86)90121-5","article-title":"Aromatase, 17\u03b2-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women","volume":"22","author":"Vermeulen","year":"1986","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/jc.81.4.1460","article-title":"Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer","volume":"81","author":"Pasqualini","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/(SICI)1097-0215(19970317)70:6<639::AID-IJC2>3.0.CO;2-W","article-title":"Concentrations of estrone, estradiol, and their sulfates and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma","volume":"70","author":"Pasqualini","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB19","first-page":"1","article-title":"Cellular and molecular pharmacology of antiestrogen action and resistance","volume":"53","author":"Clarke","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0039-128X(79)90027-8","article-title":"Aromatization of androgens by human breast cancer","volume":"33","author":"Abul-Hajj","year":"1979","journal-title":"Steroids"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/1097-0142(19870215)59:4<779::AID-CNCR2820590419>3.0.CO;2-U","article-title":"Aromatase activity in primary and metastatic human breast cancer","volume":"59","author":"Lipton","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB22","series-title":"Hormone-Dependent Cancer","first-page":"155","article-title":"Pharmacology of nonsteroidal aromatase inhibitors","author":"Bhatnagar","year":"1996"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3181\/00379727-146-38109","article-title":"Steroid sulfatase activities in human breast tumors","volume":"146","author":"Dao","year":"1974","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1210\/endo-106-4-1079","article-title":"Effects of plasma estrogen sulfates in mammary cancer cells","volume":"106","author":"Vignon","year":"1980","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01807336","article-title":"Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells","volume":"8","author":"Pasqualini","year":"1986","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB26","doi-asserted-by":"crossref","unstructured":"J.R. MacIndoe, with the technical assistance of G. Woods, L. Jeffries, M. Hinkhouse, The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells, Endocrinology 123 (1988) 1281\u20131287.","DOI":"10.1210\/endo-123-3-1281"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0022-4731(89)90077-0","article-title":"Importance of estrogen sulfates in breast cancer","volume":"34","author":"Pasqualini","year":"1989","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2265.1983.tb00051.x","article-title":"The relationship between 17\u03b2-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue","volume":"19","author":"Bonney","year":"1983","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.2910380208","article-title":"A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women","volume":"38","author":"McNeill","year":"1986","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00665786","article-title":"Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020)","volume":"34","author":"Nguyen","year":"1995","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/jcem-59-1-29","article-title":"In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway","volume":"59","author":"Santner","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB32","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/0959-8049(92)90110-N","article-title":"Steroid sulphotransferase activity in human hormone-independent MDA-MB-468 mammary cancer cells","volume":"28A","author":"Pasqualini","year":"1992","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB33","first-page":"1551","article-title":"Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines","volume":"56","author":"Falany","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB34","first-page":"173","volume":"vol. 1","author":"Pasqualini","year":"1985"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.0600003","article-title":"Estimation of oestrone sulphate, oestradiol-17\u03b2 and oestrone in peripheral plasma: concentrations during the menstrual cycle and in man","volume":"60","author":"Hawkins","year":"1974","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000180788","article-title":"Serum and urinary estrone sulfate during the menstrual cycle, measured by a direct radio-immunoassay, and fate of exogenously injected estrone sulfate","volume":"27","author":"Honjo","year":"1987","journal-title":"Horm. Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0039-128X(80)90101-4","article-title":"Plasma estrone sulfate levels in postmenopausal women","volume":"35","author":"Roberts","year":"1980","journal-title":"Steroids"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0039-128X(82)90050-2","article-title":"Plasma estrone-sulfate assessment of reduced estrogen production during treatment of metastatic breast carcinoma","volume":"39","author":"Samojlik","year":"1982","journal-title":"Steroids"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2265.1980.tb03412.x","article-title":"Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy","volume":"13","author":"Towobolla","year":"1980","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB40","first-page":"661","article-title":"Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma","volume":"44","author":"Prost","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0039-128X(71)90059-6","article-title":"The measurement of estrone sulfate in plasma","volume":"18","author":"Loriaux","year":"1971","journal-title":"Steroids"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB42","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1210\/jcem-47-5-1092","article-title":"A specific radioimmunoassay for estrone sulfate in plasma and uring without hydrolysis","volume":"47","author":"Wright","year":"1978","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0022-4731(80)90231-9","article-title":"Plasma hormones in pre- and postmenopausal breast cancer","volume":"13","author":"Drafta","year":"1980","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bjc.1990.356","article-title":"The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women ith advanced breast cancer","volume":"62","author":"Stein","year":"1990","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB45","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0959-8049(92)90120-Q","article-title":"Goserelin depot in the treatment of premenopausal advanced breast cancer","volume":"28A","author":"Blamey","year":"1992","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000227318","article-title":"Therapeutic and endocrine effects of Decapeptyl\u00ae, synthetic LH-RH agonistic analogue in premenopausal women with metastatic breast cancer\u2014a pilot phase II study","volume":"51","author":"Neskovic-Konstantinovic","year":"1994","journal-title":"Oncology"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0960-0760(94)90091-4","article-title":"Steroid gradients across the cancerous breast: an index of altered steroid metabolism in breast cancer?","volume":"51","author":"Massobrio","year":"1994","journal-title":"J. Steroid Biochem. Molec. Mol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB48","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1172\/JCI106862","article-title":"Estrone sulfate: production rate and metabolism in man","volume":"51","author":"Ruder","year":"1972","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB49","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0022-4731(81)90039-X","article-title":"The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight","volume":"14","author":"Noel","year":"1981","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB50","first-page":"3940","article-title":"Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease","volume":"43","author":"Reed","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01806013","article-title":"Oestrone sulphate, adipose tissue, and breast cancer","volume":"6","author":"Hawkins","year":"1985","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/bjc.1989.231","article-title":"Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide","volume":"60","author":"Lonning","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0960-0760(95)00017-T","article-title":"Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues","volume":"52","author":"Recchione","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB54","first-page":"2900","article-title":"Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue","volume":"45","author":"van Landeghem","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB55","series-title":"Sex Hormones and Antihormones in Endocrine-Dependent Pathology: Basic and Clinical Aspects","first-page":"257","article-title":"Control of estrone sulfatase activity and its expression in human breast cancer","volume":"vol. 1064","author":"Pasqualini","year":"1994"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB56","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/0277-5379(89)90377-5","article-title":"Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues","volume":"25","author":"Thijssen","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0014-2964(77)90173-6","article-title":"Catechol-o-methyltransferase in human breast cancer","volume":"13","author":"Assicot","year":"1977","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB58","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0277-5379(88)90124-1","article-title":"Metabolism of estradiol by human breast cancer","volume":"24","author":"Abul-Hajj","year":"1988","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB59","first-page":"2269","article-title":"Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis","volume":"58","author":"Zhu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB60","first-page":"5926","article-title":"Effects of 17\u03b2-estradiol metabolites on cell cycle events in MCF-7 and HeLa cells","volume":"52","author":"Lottering","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB61","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0024-3205(02)02305-6","article-title":"The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells","volume":"72","author":"Lippert","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0039-128X(80)90062-8","article-title":"Comparative properties of the catechol estrogens: I. Methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors","volume":"36","author":"Merriam","year":"1980","journal-title":"Steroids"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1592\/phco.23.2.165.32088","article-title":"2-Methoxyestradiol, a promising anticancer agent","volume":"23","author":"Lakhani","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0960-0760(93)90319-R","article-title":"Catecholestrogens are MCF-7 cell estrogen receptor agonists","volume":"46","author":"Sch\u00fctze","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5122(02)00141-X","article-title":"Estradiol metabolism and malignant disease","volume":"43","author":"Mueck","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB66","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0039-128X(92)90097-S","article-title":"Gas chromatography\/mass spectrometry of catechol estrogens","volume":"57","author":"Castagnetta","year":"1992","journal-title":"Steroids"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB67","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1073\/pnas.93.8.3294","article-title":"4-Hydroxylation of estrogens as marker of human mammary tumors","volume":"93","author":"Liehr","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB68","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jcem-51-3-611","article-title":"Biological properties of 16\u03b1-hydroxyestrone: implications in estrogen physiology and pathophysiology","volume":"51","author":"Fishman","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0039-128X(92)90058-H","article-title":"Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cells","volume":"57","author":"Suto","year":"1992","journal-title":"Steroids"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01990031","article-title":"Coordinated expression of intermediate biomarkers for tumorigenic transformation in ras-transfected mouse mammary epithelial cells","volume":"18","author":"Telang","year":"1991","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1677\/jme.0.0270293","article-title":"Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cells","volume":"27","author":"Lewis","year":"2001","journal-title":"J. Molec. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-4731(86)90037-3","article-title":"Aromatase inhibitors and treatment of breast cancer","volume":"24","author":"Brodie","year":"1986","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB73","first-page":"2109","article-title":"Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor Vorozole","volume":"57","author":"de Jong","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/bbrc.1996.6038","article-title":"Steroid sulfatase activity in osteoblast cells","volume":"231","author":"Fujikawa","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB75","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0959-437X(97)80153-0","article-title":"The sulfatase gene family","volume":"7","author":"Parenti","year":"1997","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB76","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/0264-6021:3550361","article-title":"Up-regulation of steroid sulphatase activity in HL60 promyelocytic cells by retinoids and 1alpha,25-dihydroxyvitamin D3","volume":"355","author":"Hughes","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3835(88)90001-8","article-title":"Effect of tamoxifen and tamoxifen derivatives on the conversion of estrone-sulfate to estradiol in the MCF-7 and R-27 mammary cancer cell lines","volume":"40","author":"Pasqualini","year":"1988","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB78","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0960-0760(90)90483-2","article-title":"Antiestrogen action in mammary cancer and in fetal cells","volume":"37","author":"Pasqualini","year":"1990","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB79","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01980971","article-title":"Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs. independent human breast cancer cell lines","volume":"18","author":"Pasqualini","year":"1991","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB80","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0960-0760(93)90007-J","article-title":"Inhibition of estrone sulfatase and 17\u03b2-hydroxysteroid dehydrogenase by antiestrogens","volume":"45","author":"Santner","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0960-0760(92)90358-P","article-title":"Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer","volume":"41","author":"Pasqualini","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB82","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0304-3835(92)90280-9","article-title":"Effect of the progestagen R-5020 (Promegestone) and of progesterone on the uptake and on the transformation of estrone sulfate in the MCF-7 and T-47D human mammary cancer cells: correlation with progesterone receptor levels","volume":"66","author":"Pasqualini","year":"1992","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB83","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0960-0760(96)00094-5","article-title":"Effect of nomegestrol acetate on estrone-sulfatase and 17\u03b2-hydroxysteroid dehydrogenase activities in human breast cancer cells","volume":"58","author":"Chetrite","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0960-0760(99)00095-3","article-title":"Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines","volume":"70","author":"Chetrite","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB85","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0960-0760(03)00058-X","article-title":"Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate","volume":"84","author":"Pasqualini","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"S1","key":"10.1016\/j.bbcan.2004.03.001_BIB86","first-page":"S7","article-title":"Differential effects of progestins on breast tissue enzymes","volume":"46","author":"Pasqualini","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB87","series-title":"Breast Cancer: Prognosis, Treatment and Prevention","first-page":"187","article-title":"The selective estrogen enzyme modulators (SEEM) in breast cancer","author":"Pasqualini","year":"2002"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB88","first-page":"135","article-title":"Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells","volume":"17","author":"Chetrite","year":"1997","journal-title":"Anticancer Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2004.03.001_BIB89","first-page":"S99","article-title":"Effect of tibolone and its two hydroxy metabolites on estrone sulfatase activity in human breast cancer tissue","volume":"76","author":"Pasqualini","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB90","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0960-0760(94)00176-M","article-title":"Estrogenicity, antiestrogenecity and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol","volume":"52","author":"Selcer","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB91","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/jm00028a002","article-title":"Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential","volume":"37","author":"Howarth","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB92","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ijc.2910630119","article-title":"In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate","volume":"63","author":"Purohit","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB93","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0960-0760(95)00214-6","article-title":"Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application","volume":"55","author":"Elger","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0960-0760(00)00062-5","article-title":"Steroid sulfatase inhibitor alters blood pressure and steroid profiles in hypertensive rats","volume":"73","author":"Valigora","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB95","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1021\/ja00118a034","article-title":"Molecular recognition in biological systems: phosphate esters vs. sulfate esters and the mechanism of action of steroid sulfatase","volume":"117","author":"Anderson","year":"1995","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB96","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1021\/jm0001166","article-title":"Structure\u2013activity relationships of 17alpha-derivates of estradiol as inhibitors of steroid-sulfatase","volume":"43","author":"Boivin","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB97","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0960-894X(98)00330-8","article-title":"17\u03b1-alkyl- or 17\u03b1-substituted benzyl-17\u03b2-estradiols: a new family of estrone-sulfatase inhibitors","volume":"8","author":"Poirier","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB98","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/jm980677l","article-title":"Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17\u03b1-benzyl (or 4\u2032-tert-butylbenzyl)estra-1,3,5(10)-trienes: combinaison of two substituents at positions C3 and C17\u03b1 of estradiol","volume":"42","author":"Ciobanu","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB99","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0960-0760(97)00196-9","article-title":"The development of a-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduce oestrogenecity","volume":"64","author":"Purohit","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0303-7207(00)00428-7","article-title":"Non-steroidal and steroidal sulfamates: new drugs for cancer therapy","volume":"171","author":"Purohit","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB101","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0960-0760(00)00178-3","article-title":"Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates","volume":"75","author":"Malini","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0960-0760(95)00244-8","article-title":"Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism","volume":"57","author":"Woo","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB103","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1074-5521(00)00023-5","article-title":"Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates","volume":"7","author":"Woo","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB104","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0960-0760(01)00080-2","article-title":"Paradoxical effect of estradiol: it can block its own bioformation in human breast cancer cells","volume":"78","author":"Pasqualini","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB105","first-page":"1589","article-title":"Effect of the progestagen promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells","volume":"14","author":"Pasqualini","year":"1994","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB106","first-page":"S99","article-title":"Control and expression of oestrone sulphatase activities in human breast cancer","volume":"150","author":"Pasqualini","year":"1996","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB107","first-page":"931","article-title":"Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164,384 on the oestrone sulphatase activity of human breast cancer cells","volume":"13","author":"Chetrite","year":"1993","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB108","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0960-0760(00)00177-1","article-title":"Regulation of steroid sulphatase expression and activity in breast cancer","volume":"75","author":"Newman","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0960-0760(00)00060-1","article-title":"Elevated steroid sulfatase expression in breast cancers","volume":"73","author":"Utsumi","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/ijc.1525","article-title":"Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers","volume":"94","author":"Miyoshi","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB111","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1006\/bbrc.1994.1637","article-title":"Human liver estrogen sulfotransferase: identification by cDNA cloning and expression","volume":"200","author":"Aksoy","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB112","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0960-0760(01)00025-5","article-title":"High metabolization of catecholestrogens by type 1 estrogen sulfotransferase (h EST 1)","volume":"77","author":"Faucher","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB113","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0960-0760(91)90248-4","article-title":"Metabolism of the oral contraceptive steroids ethynylestradiol and norgestimate by normal (Huma 7) and malignant (MCF-7 and ZR 75-1) human breast cells in culture","volume":"39","author":"Wild","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB114","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1677\/erc.0.0020227","article-title":"Oestrogen sulphotransferases in malignant and normal human breast tissue","volume":"2","author":"Anderson","year":"1995","journal-title":"Endocr.-Relat. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB115","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1073\/pnas.88.9.3520","article-title":"Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumour antigen with a recombinant retrovirus","volume":"88","author":"Bartek","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB116","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0960-0760(94)00180-T","article-title":"Estradiol stimulates c-myc proto-oncogene expression in normal human breast epithelial cells in culture","volume":"52","author":"Leygue","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB117","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1210\/jcem-73-1-8","article-title":"Estradiol and progesterone receptors in culture normal breast epithelial cells and fibroblasts: immunocytochemical studies","volume":"73","author":"Malet","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB118","first-page":"555","article-title":"Expression of estrogen sulfotransferase in MCF-7 cells by cDNA transfection suppresses the estrogen response: potential role of the enzyme in regulating estrogen-dependent growth of breast epithelial cells","volume":"286","author":"Qian","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB119","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0960-0760(93)90102-3","article-title":"Identification and characterization of cytosolic sulfotransferase activities in MCF-7 human breast carcinoma cells","volume":"46","author":"Falany","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB120","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/0022-4731(83)91116-0","article-title":"Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma","volume":"19","author":"Tseng","year":"1983","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB121","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0022-4731(90)90190-4","article-title":"Properties of estrogen and hydroxysteroid sulphotransferases in human mammary cancer","volume":"36","author":"Adams","year":"1990","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB122","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/0959-8049(94)00244-Y","article-title":"Immunohistochemical localisation of hydroxysteroid sulphotransferase in human breast carcinoma tissue: a preliminary study","volume":"30A","author":"Sharp","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB123","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0960-0760(94)90077-9","article-title":"Steroid sulfation by expressed human cytosolic sulfotransferases","volume":"48","author":"Falany","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB124","first-page":"589","article-title":"Regulation of estrogen activity by sulfation in human MCF-7 human breast cancer cells","volume":"9","author":"Falany","year":"1997","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0960-0760(98)00163-0","article-title":"Effect of medrogestone on 17\u03b2-hydroxysteroid dehydrogenase activity in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines","volume":"68","author":"Chetrite","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0960-0760(99)00095-3","article-title":"Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cells lines","volume":"70","author":"Chetrite","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB127","first-page":"81","article-title":"Placebo-controlled cross-over study of the effects of Org OD 14 in menopausal women","volume":"6","author":"Kicovic","year":"1982","journal-title":"Reproduccion"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB128","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1210\/jc.81.7.2419","article-title":"Tibolone: prevention of bone loss in late postmenopausal women","volume":"81","author":"Bjarnason","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB129","first-page":"269","article-title":"Effect of Org OD14 (Livial\u00ae) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cells lines","volume":"19","author":"Chetrite","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0960-0760(95)00015-R","article-title":"Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase","volume":"52","author":"Falany","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB131","doi-asserted-by":"crossref","first-page":"28200","DOI":"10.1016\/S0021-9258(18)46914-1","article-title":"Structure of human estrogen and aryl sulfotransferase gene","volume":"269","author":"Bernier","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB132","first-page":"S87","article-title":"Steroid sulfotransferases","volume":"150","author":"Luu-The","year":"1996","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB133","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0960-0760(98)00063-6","article-title":"Human estrogen sulfotransferase (hEST1) activities and its mRNA in various breast cancer cell lines. Effect of the progestin, promegestone (R-5020)","volume":"66","author":"Chetrite","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB134","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000478-198606000-00003","article-title":"A correlative morphologic study of human breast and endometrium in the menstrual cycle","volume":"10","author":"Longacre","year":"1986","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1152\/physrev.1980.60.4.1049","article-title":"Multiple hormone interactions in the developmental biology of the mammary gland","volume":"60","author":"Topper","year":"1980","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB136","series-title":"Breast Cancer, Prognosis, Treatment, and Prevention","first-page":"555","article-title":"Mechanisms involved in carcinogenesis of the breast","author":"Russo","year":"2002"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB137","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1210\/en.136.1.164","article-title":"The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone","volume":"136","author":"Laidlaw","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB138","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem-63-5-1174","article-title":"Progestin effect on cell proliferation and 17\u03b2-hydroxysteroid dehydrogenase activity in normal human breast cells in culture","volume":"63","author":"Gompel","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB139","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0960-0760(00)00061-3","article-title":"Progesterone effect on cell growth, ultrastructural aspect and estradiol receptors of normal human breast epithelial (HBE) cells in culture","volume":"73","author":"Malet","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB140","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/1097-0142(19841101)54:9<1920::AID-CNCR2820540924>3.0.CO;2-F","article-title":"The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice","volume":"54","author":"McManus","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB141","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/1097-0142(19870115)59:2<281::AID-CNCR2820590218>3.0.CO;2-A","article-title":"Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth","volume":"59","author":"Longman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB142","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1210\/jcem-56-6-1124","article-title":"Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture","volume":"56","author":"Vignon","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB143","first-page":"167","article-title":"Growth inhibition and increase of insulin receptors in antiestrogen-resistant T-47Dco human breast cancer cells by progestins: implication for endocrine therapies","volume":"45","author":"Horwitz","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB144","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/MCB.11.10.5032","article-title":"Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos and c-myc genes","volume":"11","author":"Musgrove","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0960-0760(94)90170-8","article-title":"Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells","volume":"50","author":"Botella","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB146","first-page":"6539","article-title":"Estrogenic potential in oral contraceptives to stimulate human breast cancer cell proliferation","volume":"52","author":"Jeng","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB147","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0960-0760(95)00171-U","article-title":"Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity","volume":"55","author":"Catherino","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB148","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0303-7207(94)90096-5","article-title":"Synthetic progestins induce proliferaton of breast tumor cell lines via the progesterone or estrogen receptor","volume":"102","author":"Kalkhoven","year":"1994","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB149","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jcp.1041240305","article-title":"Effects of interaction between estradiol-17\u03b2 and progesterone on the proliferation of cloned breast tumor cells (MCF-7 and T-47D)","volume":"124","author":"Schatz","year":"1985","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0303-7207(77)90108-3","article-title":"Comparison of the in vitro conversion of estradiol-17\u03b2 to estrone of normal and neoplastic human breast tissue","volume":"6","author":"Pollow","year":"1977","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB151","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1006217400137","article-title":"17\u03b2-Hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue","volume":"57","author":"Miettinen","year":"1999","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB152","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/endo-114-5-1483","article-title":"17\u03b2-Hydroxysteroid dehydrogenase activity in human breast epithelial cells and fibroblast cultures","volume":"114","author":"Prudhomme","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB153","first-page":"290","article-title":"17\u03b2-Hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin","volume":"52","author":"Poutanen","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB154","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1210\/en.132.1.179","article-title":"Androgen receptor-mediated stimulation of 17\u03b2-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells","volume":"132","author":"Couture","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB155","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1042\/bj3140839","article-title":"Human 17\u03b2-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression","volume":"314","author":"Miettinen","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB156","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/(SICI)1097-0215(19961127)68:5<600::AID-IJC8>3.0.CO;2-2","article-title":"Characterization of estrogen-dependent growth of cultured MCF-7 human breast-cancer cells expressing 17\u03b2-hydroxysteroid-dehydrogenase type 1","volume":"68","author":"Miettinen","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB157","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0039-128X(96)00174-2","article-title":"The key role of 17\u03b2-hydroxysteroid dehydrogenases in sex steroid biology","volume":"62","author":"Labrie","year":"1997","journal-title":"Steroids"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB158","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0960-0760(95)00116-H","article-title":"Estrone sulfate-sulfatase and 17\u03b2-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence","volume":"53","author":"Pasqualini","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB159","first-page":"2895","article-title":"Estradiol 17\u03b2-hydroxysteroid dehydrogenases, a marker of breast cancer hormone dependency","volume":"45","author":"Fournier","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB160","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1054\/bjoc.1999.0956","article-title":"17\u03b2-Hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters","volume":"82","author":"Suzuki","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB161","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1210\/jc.85.10.3669","article-title":"3\u03b2-Hydroxysteroid dehydrogenase\/\u03945 4-isomerase activity associated with the human 17\u03b2-hydroxsteroid dehydrogenase type 2 isoform","volume":"85","author":"Suzuki","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB162","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000055281","article-title":"17-Beta-hydroxysteroid dehydrogenase in human breast and endometrial cancer\u2014a new development in intracrinology","volume":"59","author":"Sasano","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB163","first-page":"1101","article-title":"17\u03b2-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast","volume":"20","author":"Ariga","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB164","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ijc.2910460524","article-title":"Progestin induction of 17\u03b2-hydroxsteroid dehydrogenase enzyme protein in the T-47D human breast-cancer cell line","volume":"46","author":"Poutanen","year":"1990","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB165","first-page":"S21","article-title":"Expression and regulation of 17\u03b2-hydroxsteroid dehydrogenase type 1","volume":"150","author":"Peltoketo","year":"1996","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB166","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ijc.2910450131","article-title":"A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17\u03b2-hydroxysteroid dehydrogenase activity","volume":"45","author":"Coldham","year":"1990","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB167","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/joe.0.1180149","article-title":"Steroidal regulation of oestradiol-17\u03b2-dehydrogenase activity of the human breast cancer cell line MCF-7","volume":"118","author":"Adams","year":"1988","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB168","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0960-0760(91)90378-I","article-title":"17\u03b2-Estradiol dehydrogenase (E2DH) activity in T47D cells","volume":"39","author":"Malet","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB169","first-page":"261","article-title":"Effect of org OD14 (Livial\u00ae) and its metabolites on 17\u03b2-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells","volume":"19","author":"Chetrite","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/erc.0.0030041","article-title":"17\u03b2-Hydroxysteroid dehydrogenase: inhibitors and inhibitor design","volume":"3","author":"Penning","year":"1996","journal-title":"Endocr.-Relat. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB171","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0960-0760(98)00043-0","article-title":"Overview of a rational approch to design type I 17\u03b2-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation","volume":"66","author":"Tremblay","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB172","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0039-128X(94)90072-8","article-title":"N-butyl, N-methyl, 11[3\u2032,17\u2032((dihydroxy)-1\u2032,3\u2032,5\u2032(10\u2032)-estratrien-16\u2032(-yl]-9(R\/S)-bromoundecanamide: synthesis and 17\u03b2-HSD inhibiting, estrogenic and antestrogenic activities","volume":"59","author":"Pelletier","year":"1994","journal-title":"Steroids"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB173","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.96.3.840","article-title":"Structure of the ternary complex of human 17\u03b2-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+","volume":"96","author":"Sawicki","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2004.03.001_BIB174","first-page":"S111","article-title":"Expression of 17\u03b2-hydroxysteroid dehydrogenases and correlation to prognosis in postmenopausal breast cancer patients","volume":"82","author":"Gunnarsson","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB175","series-title":"Breast Cancer, Prognosis, Treatment, and Prevention","first-page":"251","article-title":"Aromatase inhibitors and their application to the treatment of breast cancer","author":"Brodie","year":"2002"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB176","series-title":"Proceedings of the VI International Aromatase Conference","first-page":"219","article-title":"Aromatase 2002","volume":"vol. 86","year":"2003"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB177","first-page":"400","article-title":"The relationship between breast cancer survival and prior postmenopausal estrogen use","volume":"80","author":"Strickland","year":"1992","journal-title":"Obstet. Gynaecol."},{"key":"10.1016\/j.bbcan.2004.03.001_BIB178","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00052671","article-title":"Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States","volume":"7","author":"Willis","year":"1996","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB179","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T","article-title":"Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy\u2014long-term follow-up of a Swedish cohort","volume":"67","author":"Persson","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1097-0215(199806)79:3<278::AID-IJC12>3.0.CO;2-5","article-title":"Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer","volume":"79","author":"Bonnier","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB181","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.bjc.6690543","article-title":"Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients","volume":"80","author":"Jernstr\u00f6m","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2004.03.001_BIB182","first-page":"278","article-title":"Potential benefits of estrogens and progestogens on breast cancer","volume":"43","author":"Schneider","year":"1998","journal-title":"Int. J. Fert. Women's Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X04000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X04000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T16:37:48Z","timestamp":1623775068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X04000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":182,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0304419X04000186"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2004.03.001","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}